Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter ended September 2023. Sales rose 200.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.07 crore during the previous quarter ended September 2023.
Particulars | Quarter Ended | ||
Sep. 2024 | Sep. 2023 | % Var. | |
Sales | 0.21 | 0.07 | 200 |
OPM % | 66.67 | 28.57 | - |
PBDT | 0.15 | 0.02 | 650 |
PBT | 0.15 | 0.02 | 650 |
NP | 0.15 | 0.02 | 650 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account